ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• KLX Energy narrows Q3 2026 revenue guidance, completes rights offering
• NV Gold closes final tranche of private placement, raising $1.4M